Conservative Treatment of Peyronie's Disease
Many men first look for ways to avoid surgery. That's understandable. This page explains which non-surgical treatments exist for Peyronie's disease, what they can achieve – and where their limits lie.
Show contents
What Conservative Therapies Can Achieve – and What They Cannot
Peyronie's disease is a condition whose conservative treatment remains a challenge to this day. There are a number of procedures that can be used sensibly in certain situations. At the same time, the scientific evidence for many of these methods is limited.
What this means: in early stages, conservative therapies can help slow the progression of the condition, relieve pain, and in some cases achieve a slight improvement in curvature. However, a reliable, complete correction of an existing pronounced curvature is generally not achievable with non-surgical means.
We are not saying this to discourage conservative measures – but so that your expectations remain realistic. Disappointing results often occur not because a method is fundamentally pointless, but because expectations were set too high.
When Conservative Treatment Is Particularly Worthwhile
Non-surgical procedures are considered above all when:
- The condition is still in the active phase
- Symptoms are mild and there is no pronounced functional impairment
- The patient prefers to initially wait and monitor
- Surgery is not currently an option for health reasons
- Conservative measures are used as an adjunct alongside other approaches
The Main Conservative Treatments for Peyronie's Disease in Detail
Collagenase
Collagenase injection is among the best-studied conservative treatments for Peyronie's disease. The enzyme aims to break down specific collagen structures within the plaque, thereby reducing the curvature.
Studies show that a reduction in curvature can be achieved in selected patients. However, results vary considerably from person to person, and not all patients respond to the treatment.
Hyaluronic Acid Injections
In recent years, research has looked into whether hyaluronic acid injections during the active phase of Peyronie's disease could have a positive effect on the course of the condition. Early studies show interesting approaches – particularly regarding an anti-inflammatory effect during the early stage of the disease.
However, the scientific evaluation is not yet complete. Hyaluronic acid injections for Peyronie's disease are not yet considered an established standard and should be regarded as an experimental approach requiring further research.
Shockwave Therapy
Shockwave therapy – also known as ESWT (extracorporeal shockwave therapy) – has been used for years to treat various musculoskeletal conditions. In Peyronie's disease, it aims to affect the plaques and improve blood flow.
The available data shows that shockwave therapy can be effective, above all, at reducing pain. Studies have not so far clearly demonstrated a reliable effect on the curvature itself. This means: shockwave therapy can be a useful measure for relieving pain and discomfort – but it is not sufficient as a method for correcting curvature.
Traction Therapy
In traction therapy, the penis is stretched daily over an extended period using a special extension device. The goal is to counteract the plaque and to limit or reduce the shortening caused by the condition.
The method requires consistent daily use over several months. Studies show moderate effects – primarily on penile length, less on the curvature itself. Traction therapy can be a useful adjunct, but is not sufficient as a sole treatment for pronounced curvature.
Medication-Based Therapies
Various orally administered medications and vitamins have been tried for Peyronie's disease. The evidence for these substances is overall weak. None of these agents has been established as a reliably effective therapy.
When medications are used, it is usually in combination with other measures or during early stages of the disease – not as a sole therapy for pronounced disease.
Conservative Methods at a Glance
| Method | Main Effect | Evidence Level | When Appropriate |
|---|---|---|---|
| Collagenase | Curvature reduction | Moderate (limited availability) | Active phase, suitable anatomy |
| Hyaluronic acid | Anti-inflammatory | Limited / experimental | Early stage |
| Shockwave therapy | Pain relief | Good for pain, weak for curvature | Patients with significant pain |
| Traction therapy | Length preservation | Moderate | As an adjunct, in cases of shortening |
| Oral medication | Variable | Weak | Early stage, adjunctive |
When Conservative Measures Are Not Enough
With pronounced curvature, significant loss of length, or marked functional impairment, conservative treatments reach their limits. In these situations, surgical treatment is the more effective option.
The decision for or against surgery is not a defeat for conservative therapies – it is a medically justified choice based on a realistic assessment of the situation. We support you in this decision without pressure.
Frequently Asked Questions About Conservative Treatment
We advise against self-treatment without medical supervision. On the one hand, many of the procedures described can only be carried out sensibly or safely under medical supervision. On the other hand, without a diagnosis it is unclear whether, and which, measure is even appropriate.
That depends on the method chosen. Traction therapies require daily use over several months. Injection procedures are carried out in treatment cycles. A realistic expectation: results generally do not appear immediately, but over a period of several months.
Yes, that is possible and, in certain situations, also sensible – particularly if the condition is still in the active phase. In the stable phase, some conservative treatments no longer provide significant benefit. We discuss this on an individual basis.
Schedule a Consultation
Whether, and which, conservative therapy makes sense for your individual situation can only be determined in a personal conversation.
The first step isn't surgery – it's clarity.
Updated on July 31, 2026
